Mengxia Fu

516 total citations
27 papers, 309 citations indexed

About

Mengxia Fu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mengxia Fu has authored 27 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mengxia Fu's work include Cardiovascular Disease and Adiposity (7 papers), Cardiac Valve Diseases and Treatments (5 papers) and Global Cancer Incidence and Screening (4 papers). Mengxia Fu is often cited by papers focused on Cardiovascular Disease and Adiposity (7 papers), Cardiac Valve Diseases and Treatments (5 papers) and Global Cancer Incidence and Screening (4 papers). Mengxia Fu collaborates with scholars based in China, United States and Switzerland. Mengxia Fu's co-authors include Lian Xu, Jiangping Song, Xiaohong Chen, Cheng‐Chao Ruan, Maoqing Ye, Pingjin Gao, Dongrui Chen, Weiqing Han, Songren Shu and Ling‐Ran Kong and has published in prestigious journals such as Nature Communications, Diabetes and Journal of Neurochemistry.

In The Last Decade

Mengxia Fu

22 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengxia Fu China 12 158 85 68 63 51 27 309
Heng-Chen Yao China 12 123 0.8× 93 1.1× 57 0.8× 32 0.5× 51 1.0× 36 334
Inès Boukhalfa France 4 109 0.7× 136 1.6× 103 1.5× 57 0.9× 24 0.5× 5 363
Hakan Tıkız Türkiye 11 123 0.8× 61 0.7× 108 1.6× 64 1.0× 72 1.4× 34 381
Shigehiko Kato Japan 10 203 1.3× 102 1.2× 55 0.8× 38 0.6× 25 0.5× 44 354
Keita Okayama Japan 9 119 0.8× 164 1.9× 108 1.6× 25 0.4× 29 0.6× 20 384
И. В. Кологривова Russia 8 203 1.3× 112 1.3× 68 1.0× 35 0.6× 70 1.4× 42 378
Stephan R. Künzel Germany 10 239 1.5× 172 2.0× 49 0.7× 54 0.9× 19 0.4× 29 451
Chunru Xu China 10 88 0.6× 147 1.7× 75 1.1× 33 0.5× 34 0.7× 29 356
Guoshuai Feng China 8 110 0.7× 122 1.4× 31 0.5× 29 0.5× 29 0.6× 10 299

Countries citing papers authored by Mengxia Fu

Since Specialization
Citations

This map shows the geographic impact of Mengxia Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxia Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxia Fu more than expected).

Fields of papers citing papers by Mengxia Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengxia Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxia Fu. The network helps show where Mengxia Fu may publish in the future.

Co-authorship network of co-authors of Mengxia Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengxia Fu. A scholar is included among the top collaborators of Mengxia Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengxia Fu. Mengxia Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Mengxia, et al.. (2025). Thyroid cancer in Asia: incidence, mortality in 2022, and future projections to 2050. European Journal of Cancer Prevention. 35(2). 126–140.
2.
Shu, Songren, Zhen Wang, Xiao Chen, et al.. (2025). Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy. BMC Medicine. 23(1). 213–213. 1 indexed citations
3.
Fu, Mengxia & Huan Zhang. (2025). Global burden of peripheral arterial disease and its risk factors, 1990–2021. BMC Cardiovascular Disorders. 25(1). 631–631.
4.
Fu, Mengxia, Yanping Li, & Jian Wang. (2025). Incidence and Mortality of Colorectal Cancer in Asia in 2022 and Projections for 2050. Journal of Gastroenterology and Hepatology. 40(5). 1143–1156. 2 indexed citations
5.
Fu, Mengxia, Songren Shu, Xiaohong Chen, et al.. (2025). Single-Cell Transcriptomics Identified Fibrosis-Activated Valve Interstitial Cells Involved in Functional Tricuspid Regurgitation. JACC Asia. 5(3). 478–495.
6.
Cui, Hao, Hao Nie, Ningning Zhang, et al.. (2025). Phenotype-Based Classification of Obstructive Hypertrophic Cardiomyopathy Undergoing Myectomy. JACC Basic to Translational Science. 10(5). 568–583.
7.
Fu, Mengxia, et al.. (2025). Assessing the African burden of breast cancer: A demographic analysis using Global Cancer Observatory 2022. European Journal of Surgical Oncology. 51(5). 109627–109627. 1 indexed citations
9.
10.
Fu, Mengxia, et al.. (2024). Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050. The Breast. 79. 103835–103835. 14 indexed citations
11.
Li, Yan, Yi‐Jun Lin, Mengxia Fu, et al.. (2024). Aging aggravates aortic aneurysm and dissection via miR-1204-MYLK signaling axis in mice. Nature Communications. 15(1). 5985–5985. 15 indexed citations
12.
13.
Shu, Songren, Yicheng Yang, Bo Sun, et al.. (2023). Alerting trends in epidemiology for calcific aortic valve disease, 1990–2019: An age–period–cohort analysis for the Global Burden of Disease Study 2019. European Heart Journal - Quality of Care and Clinical Outcomes. 9(5). 459–473. 16 indexed citations
14.
Fu, Mengxia, Songren Shu, Xiaorui Liu, et al.. (2023). Single-Cell RNA Sequencing of Coronary Perivascular Adipose Tissue From End-Stage Heart Failure Patients Identifies SPP1 + Macrophage Subpopulation as a Target for Alleviating Fibrosis. Arteriosclerosis Thrombosis and Vascular Biology. 43(11). 2143–2164. 37 indexed citations
15.
Fu, Mengxia & Jiangping Song. (2022). Single-cell RNA sequencing reveals the diversity and biology of valve cells in cardiac valve disease. Journal of Cardiology. 81(1). 49–56. 1 indexed citations
16.
Fu, Mengxia & Jiangping Song. (2021). Single-Cell Transcriptomics Reveals the Cellular Heterogeneity of Cardiovascular Diseases. Frontiers in Cardiovascular Medicine. 8. 643519–643519. 12 indexed citations
17.
Chen, Caiyun, Yuquan Li, Yan Li, et al.. (2020). Circulating extracellular vesicles from patients with valvular heart disease induce neutrophil chemotaxis via FOXO3a and the inhibiting role of dexmedetomidine. American Journal of Physiology-Endocrinology and Metabolism. 319(1). E217–E231. 11 indexed citations
18.
Xu, Lian, Mengxia Fu, Shi Peng, et al.. (2020). Isolation, Culture, and Adipogenic Induction of Neural Crest Original Adipose-Derived Stem Cells from Periaortic Adipose Tissue. Journal of Visualized Experiments. 3 indexed citations
19.
Xu, Lian, Mengxia Fu, Dongrui Chen, et al.. (2019). Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition. BMB Reports. 52(10). 595–600. 32 indexed citations
20.
Ye, Maoqing, Cheng‐Chao Ruan, Mengxia Fu, et al.. (2018). Developmental and functional characteristics of the thoracic aorta perivascular adipocyte. Cellular and Molecular Life Sciences. 76(4). 777–789. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026